Microglial activation machinery

Microglial activation machinery refers to the collective set of receptors, signaling cascades, and effector proteins that mediate the response of microglia, the resident immune cells of the central nervous system, to pathological stimuli. This machinery includes pattern recognition receptors like Toll-like receptors (TLRs), triggering receptors expressed on myeloid cells 2 (TREM2), and purinergic receptors (e.g., P2X7), which sense damage-associated molecular patterns (DAMPs). Upon activation, these pathways trigger downstream transcription factors such as NF-kB and the assembly of the NLRP3 inflammasome, leading to the release of neurotoxic or neuroprotective factors. While acute activation is a protective response to injury, chronic or dysregulated microglial activation is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's, where it contributes to progressive neuronal loss. Therapeutic strategies often aim to modulate this machinery to suppress chronic neuroinflammation while preserving the cells' essential homeostatic and phagocytic functions.

Other names

Microglial activation pathwaysNeuroinflammatory signaling complexMicroglial polarization machinery

Drugs targeting microglial activation typically act by modulating specific receptors (e.g., TREM2, P2X7, TLR4) or signaling pathways (e.g., NF-kB, NLRP3 inflammasome) to shift microglia from a pro-inflammatory (M1-like) to a pro-resolving or homeostatic (M2-like) state.